Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.